203 related articles for article (PubMed ID: 35204461)
1. EPHA2, EPHA4, and EPHA7 Expression in Triple-Negative Breast Cancer.
Nikas I; Giaginis C; Petrouska K; Alexandrou P; Michail A; Sarantis P; Tsourouflis G; Danas E; Pergaris A; Politis PK; Nakopoulou L; Theocharis S
Diagnostics (Basel); 2022 Feb; 12(2):. PubMed ID: 35204461
[TBL] [Abstract][Full Text] [Related]
2. Expression Pattern and Prognostic Value of EPHA/EFNA in Breast Cancer by Bioinformatics Analysis: Revealing Its Importance in Chemotherapy.
Liang Z; Wang X; Dong K; Li X; Qin C; Zhou H
Biomed Res Int; 2021; 2021():5575704. PubMed ID: 33977106
[TBL] [Abstract][Full Text] [Related]
3. Expression of ephrin-A ligands and EphA receptors in the developing mouse tooth and its supporting tissues.
Luukko K; Løes S; Kvinnsland IH; Kettunen P
Cell Tissue Res; 2005 Jan; 319(1):143-52. PubMed ID: 15517401
[TBL] [Abstract][Full Text] [Related]
4. Eph/ephrin profiling in human breast cancer reveals significant associations between expression level and clinical outcome.
Brantley-Sieders DM; Jiang A; Sarma K; Badu-Nkansah A; Walter DL; Shyr Y; Chen J
PLoS One; 2011; 6(9):e24426. PubMed ID: 21935409
[TBL] [Abstract][Full Text] [Related]
5. Small molecules can selectively inhibit ephrin binding to the EphA4 and EphA2 receptors.
Noberini R; Koolpe M; Peddibhotla S; Dahl R; Su Y; Cosford ND; Roth GP; Pasquale EB
J Biol Chem; 2008 Oct; 283(43):29461-72. PubMed ID: 18728010
[TBL] [Abstract][Full Text] [Related]
6. Stem-like Cells from Invasive Breast Carcinoma Cell Line MDA-MB-231 Express a Distinct Set of Eph Receptors and Ephrin Ligands.
Lucero M; Thind J; Sandoval J; Senaati S; Jimenez B; Kandpal RP
Cancer Genomics Proteomics; 2020; 17(6):729-738. PubMed ID: 33099474
[TBL] [Abstract][Full Text] [Related]
7. Expression of Eph receptors in skeletal muscle and their localization at the neuromuscular junction.
Lai KO; Ip FC; Cheung J; Fu AK; Ip NY
Mol Cell Neurosci; 2001 Jun; 17(6):1034-47. PubMed ID: 11414792
[TBL] [Abstract][Full Text] [Related]
8. EphA4 is a prognostic factor in gastric cancer.
Miyazaki K; Inokuchi M; Takagi Y; Kato K; Kojima K; Sugihara K
BMC Clin Pathol; 2013 Jun; 13(1):19. PubMed ID: 23738943
[TBL] [Abstract][Full Text] [Related]
9. Clinical genomic profiling to identify actionable alterations for very early relapsed triple-negative breast cancer patients in the Chinese population.
Wang L; Zhai Q; Lu Q; Lee K; Zheng Q; Hong R; Wang S
Ann Med; 2021 Dec; 53(1):1358-1369. PubMed ID: 34396843
[TBL] [Abstract][Full Text] [Related]
10. Human dendritic cells express neuronal Eph receptor tyrosine kinases: role of EphA2 in regulating adhesion to fibronectin.
de Saint-Vis B; Bouchet C; Gautier G; Valladeau J; Caux C; Garrone P
Blood; 2003 Dec; 102(13):4431-40. PubMed ID: 12907451
[TBL] [Abstract][Full Text] [Related]
11. CYPOR is a novel and independent prognostic biomarker of recurrence-free survival in triple-negative breast cancer patients.
Pedersen MH; Hood BL; Ehmsen S; Beck HC; Conrads TP; Bak M; Ditzel HJ; Leth-Larsen R
Int J Cancer; 2019 Feb; 144(3):631-640. PubMed ID: 30110125
[TBL] [Abstract][Full Text] [Related]
12. Ephrin Receptor A4 is a New Kaposi's Sarcoma-Associated Herpesvirus Virus Entry Receptor.
Chen J; Zhang X; Schaller S; Jardetzky TS; Longnecker R
mBio; 2019 Feb; 10(1):. PubMed ID: 30782663
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation of EphA2 receptor and vasculogenic mimicry is an indicator of poor prognosis in invasive carcinoma of the breast.
Mitra D; Bhattacharyya S; Alam N; Sen S; Mitra S; Mandal S; Vignesh S; Majumder B; Murmu N
Breast Cancer Res Treat; 2020 Jan; 179(2):359-370. PubMed ID: 31686261
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical co-expression status of cytokeratin 5/6, androgen receptor, and p53 as prognostic factors of adjuvant chemotherapy for triple negative breast cancer.
Maeda T; Nakanishi Y; Hirotani Y; Fuchinoue F; Enomoto K; Sakurai K; Amano S; Nemoto N
Med Mol Morphol; 2016 Mar; 49(1):11-21. PubMed ID: 26009308
[TBL] [Abstract][Full Text] [Related]
15. Effects of altered ephrin-A5 and EphA4/EphA7 expression on tumor growth in a medulloblastoma mouse model.
Bhatia S; Hirsch K; Baig NA; Rodriguez O; Timofeeva O; Kavanagh K; Lee YC; Wang XJ; Albanese C; Karam SD
J Hematol Oncol; 2015 Sep; 8():105. PubMed ID: 26345456
[TBL] [Abstract][Full Text] [Related]
16. Identification of potent pan-ephrin receptor kinase inhibitors using DNA-encoded chemistry technology.
Madasu C; Liao Z; Parks SE; Sharma KL; Bohren KM; Ye Q; Li F; Palaniappan M; Tan Z; Yuan F; Creighton CJ; Tang S; Masand RP; Guan X; Young DW; Monsivais D; Matzuk MM
Proc Natl Acad Sci U S A; 2024 May; 121(19):e2322934121. PubMed ID: 38701119
[TBL] [Abstract][Full Text] [Related]
17. EPHA2, EPHA4, and EPHA6 Expression in Uveal Melanomas: Searching for the Culprits of Neoplasia.
Pergaris A; Danas E; Gajdzis P; Levidou G; Gajdzis M; Cassoux N; Gardrat S; Donizy P; Korkolopoulou P; Kavantzas N; Klijanienko J; Theocharis S
Diagnostics (Basel); 2022 Apr; 12(5):. PubMed ID: 35626181
[TBL] [Abstract][Full Text] [Related]
18. Eicosapentaenoic acid in combination with EPHA2 inhibition shows efficacy in preclinical models of triple-negative breast cancer by disrupting cellular cholesterol efflux.
Torres-Adorno AM; Vitrac H; Qi Y; Tan L; Levental KR; Fan YY; Yang P; Chapkin RS; Eckhardt BL; Ueno NT
Oncogene; 2019 Mar; 38(12):2135-2150. PubMed ID: 30459358
[TBL] [Abstract][Full Text] [Related]
19. Parcellation of the thalamus into distinct nuclei reflects EphA expression and function.
Lehigh KM; Leonard CE; Baranoski J; Donoghue MJ
Gene Expr Patterns; 2013 Dec; 13(8):454-63. PubMed ID: 24036135
[TBL] [Abstract][Full Text] [Related]
20. The expressions of NEDD9 and E-cadherin correlate with metastasis and poor prognosis in triple-negative breast cancer patients.
Li P; Sun T; Yuan Q; Pan G; Zhang J; Sun D
Onco Targets Ther; 2016; 9():5751-5759. PubMed ID: 27703373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
